SJStig O. P. Jacobsson

Stig O. P. Jacobsson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stig O. P. Jacobsson has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models

    by Dina Rönnberg, Stig O.P. Jacobsson

    Background: Piperazine derivatives such as BZP and TFMPP have been used as “party pill” substitutes for MDMA and are associated with neurological and cardiovascular toxicity. While their psychoactive effects are largely attributed to monoaminergic mechanisms, the cellular pathways underlying their toxicity are less well defined. Previous in vitro studies indicate mitochondrial dysfunction and oxidative stress, but potential effects on the neuronal cytoskeleton, specifically microtubules, have not been systematically investigated. Methods: The effects of MeOPP, BZP, pFPP and TFMPP were evaluated in retinoic acid–differentiated P19 mouse embryonal carcinoma–derived neurons using complementary assays of cell viability (calcein-AM), metabolic activity (MTT), membrane integrity (LDH), mitochondrial membrane potential (TMRE) and βIII-tubulin immunofluorescence. Key findings were evaluated in differentiated human SH-SY5Y neuroblastoma cells and in Caco-2 human colorectal adenocarcinoma cells. Tubulin polymerization was assessed in a complementary cell-free assay. Results: All compounds induced concentration-dependent toxicity, with marked differences in potency and efficacy. TFMPP was the most active compound across endpoints, producing early and sustained loss of mitochondrial membrane potential followed by reduced viability, cytoskeletal changes and increased membrane damage. BZP and pFPP showed moderate toxicity at higher concentrations, whereas MeOPP had limited effects. Time-course analysis demonstrated that mitochondrial depolarization preceded membrane damage. Reduced βIII-tubulin immunofluorescence in neuronal cells, together with inhibition of tubulin polymerization in a cell-free system, is consistent with effects on microtubule-related processes. Similar toxicity patterns were observed in SH-SY5Y cells, and cytotoxic effects of BZP and TFMPP were also detected in Caco-2 cells. Conclusions: Piperazine derivatives are associated with cellular toxicity characterized by early mitochondrial dysfunction and subsequent effects on the neuronal cytoskeleton. TFMPP showed the most consistent activity across models. The findings indicate that microtubule-related processes may contribute to toxicity and support further mechanistic studies beyond monoaminergic pathways.

  • Open Access

    Effects of cannabinoids on the development of chick embryos in ovo

    by Sofia B. Gustafsson, Stig O. P. Jacobsson

    We have examined the effects of the synthetic cannabinoids HU 210 and HU 211, the plant-derived cannabidiol and the endogenous cannabinoid anandamide on the viability and development of chick embryos. Fertilized White Leghorn chicken eggs were injected with the test compounds or carrier vehicle, via a drilled small hole in the egg, directly into the egg yolk. After nine days of exposure, the embryonal viability, length and wet weight of embryos, and wet weight of brains were measured, and the development stages were assessed according to the Hamburger and Hamilton (HH) scale. The potent synthetic cannabinoid receptor agonist HU 210 and the non-psychotropic cannabidiol were embryotoxic at the highest concentrations examined (10 µM and 50 µM, respectively), with no viable embryos after the HU 210 injection, and 20% viability after the cannabidiol injections. The effects of HU 210 on the chick embryo were attenuated by α-tocopherol and the cannabinoid receptor antagonist AM251, whereas only α-tocopherol gave a statistically significant protection against the embryotoxic effects of cannabidiol. This study shows that exposure to plant-derived or synthetic cannabinoids during early embryonal development decreases embryonal viability. Extrapolation of data across species is of course difficult, but the data would argue against the use of cannabinoids, be it recreationally or therapeutically, during pregnancy.


  • Open Access

    Comparison of neurons derived from mouse P19, rat PC12 and human SH-SY5Y cells in the assessment of chemical- and toxin-induced neurotoxicity

    by Dina Popova, Jessica Karlsson, Stig O. P. Jacobsson

    Exposure to chemicals might be toxic to the developing brain. There is a need for simple and robust in vitro cellular models for evaluation of chemical-induced neurotoxicity as a complement to traditional studies on animals. In this study, neuronally differentiated mouse embryonal carcinoma P19 cells (P19 neurons) were compared with human neuroblastoma SH-SY5Y cells and rat adrenal pheochromocytoma PC12 cells for their ability to detect toxicity of methylmercury (MeHg), okadaic acid and acrylamide. Retinoic acid-treated P19 and SH-SY5Y cells and nerve growth factor-stimulated PC12 cells, allowed to differentiate for 6 days, were exposed to MeHg, okadaic acid and acrylamide for 48 h. Cell survival and neurite outgrowth were assessed with the calcein-AM assay and fluorescence detection of antibodies against the cytoskeletal neuron-specific protein βIII-tubulin, respectively. The effects of glutathione (GSH) and the potent inhibitor of GSH synthesis buthionine sulfoximine (BSO) on the MeHg induced-toxicity were assessed using the PrestoBlue™ cell viability assay and the TMRE mitochondrial membrane potential assay. Differentiated P19 cells developed the most extensive neuronal network among the three cell models and were the most sensitive neuronal model to detect neurotoxic effects of the test compounds. MeHg produced a concentration-dependent toxicity in differentiated P19 cells and SH-SY5Y cells, with statistically significant effects at concentrations from 0.1 μM in the P19 neurons and 1 μM in the SH-SY5Y cells. MeHg induced a decrease in the cellular metabolic activity and mitochondrial membrane potential (ΔΨm) in the differentiated P19 cells and SH-SY5Y cells, that were attenuated by GSH. Okadaic acid and acrylamide also showed statistically significant toxicity in the P19 neurons, but not in the SH-SY5Y cells or the P12 cells. P19 neurons are more sensitive to detect cytotoxicity of MeHg, okadaic acid and acrylamide than retinoic acid-differentiated SH-SY5Y cells and nerve growth factor-treated PC12 cells. P19 neurons are at least as sensitive as differentiated SH-SY5Y cells to detect the loss of mitochondrial membrane potential produced by MeHg and the protective effects of extracellular GSH on MeHg toxicity. P19 neurons may be a useful model to study neurotoxic effects of chemicals.


  • Open Access

    Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells

    by Dina Popova, Andréas Forsblad, Sanaz Hashemian, Stig O. P. Jacobsson

    3,4-methylenedioxymethamphetamine (MDMA; ecstasy) is a commonly abused recreational drug that causes neurotoxic effects in both humans and animals. The mechanism behind MDMA-induced neurotoxicity is suggested to be species-dependent and needs to be further investigated on the cellular level. In this study, the effects of MDMA in neuronally differentiated P19 mouse embryonal carcinoma cells have been examined. MDMA produces a concentration-, time- and temperature-dependent toxicity in differentiated P19 neurons, as measured by intracellular MTT reduction and extracellular LDH activity assays. The P19-derived neurons express both the serotonin reuptake transporter (SERT), that is functionally active, and the serotonin metabolizing enzyme monoamine oxidase A (MAO-A). The involvement of these proteins in the MDMA-induced toxicity was investigated by a pharmacological approach. The MAO inhibitors clorgyline and deprenyl, and the SERT inhibitor fluoxetine, per se or in combination, were not able to mimic the toxic effects of MDMA in the P19-derived neurons or block the MDMA-induced cell toxicity. Oxidative stress has been implicated in MDMA-induced neurotoxicity, but pre-treatment with the antioxidants α-tocopherol or N-acetylcysteine did not reveal any protective effects in the P19 neurons. Involvement of mitochondria in the MDMA-induced cytotoxicity was also examined, but MDMA did not alter the mitochondrial membrane potential (ΔΨm) in the P19 neurons. We conclude that MDMA produce a concentration-, time- and temperature-dependent neurotoxicity and our results suggest that the mechanism behind MDMA-induced toxicity in mouse-derived neurons do not involve the serotonergic system, oxidative stress or mitochondrial dysfunction.


  • Expression of functional CB1cannabinoid receptors in retinoic acid‐differentiated P19 embryonal carcinoma cells

    by Anna C. Svensson, Mattias Johansson, Emma Persson, Marta San Celestino Carchenilla, Stig O.P. Jacobsson

    Although primary neuronal cell cultures, usually obtained from embryonic or early postnatal rodents, have been used in vitro to study the neural cannabinoid signalling system, development of cell lines with neural properties exhibiting native expression of cannabinoid receptors is desirable. This study was undertaken to investigate the expression of CB1and CB2cannabinoid receptors in neurons that develop from retinoic acid (RA)‐primed mouse P19 embryonal carcinoma cells. Both undifferentiated P19 cells and RA‐treated P19 neurons were positive, by using reverse transcription‐polymerase chain reaction (RT‐PCR), for CB1(but not CB2) mRNA. Neuronal differentiation increased the CB1mRNA expression, and Western blotting with a CB1receptor antibody showed a strong immunoreactive band at approximately 62 kDa in membranes from P19‐derived neurons. The cannabinoid receptor agonists CP 55,940 and HU‐210 produced concentration‐dependent inhibition of forskolin‐induced (3 μM) cyclic AMP production in the P19‐derived neurons (29% at 1 μM CP 55,940 and 34% at 1 μM HU‐210), which could be blocked by the CB1‐selective receptor antagonist AM251, but not by the CB2‐selective antagonist AM630. Furthermore, glutamate (100 μM) induced a sustained increase in [Ca2+]iin P19‐derived neurons that could be concentration‐dependently blocked by the cannabinoid receptor agonists WIN 55,212‐2. Thus, the protocol used provides an in vitro model system expressing CB1cannabinoid receptors at the level of mRNA, protein, and AM251‐sensitive agonist‐induced inhibition of intracellular cyclic AMP accumulation, which may be useful to investigate the developmental regulation, expression and function of neuronal cannabinoid receptors.


  • Characterization of palmitoylethanolamide transport in mouse Neuro‐2a neuroblastoma and rat RBL‐2H3 basophilic leukaemia cells: comparison with anandamide

    by Stig O P Jacobsson, Christopher J Fowler

    The endogenous cannabinoid receptor agonist anandamide (AEA) and the related compound palmitoylethanolamide (PEA) are inactivated by transport into cells followed by metabolism by fatty acid amide hydrolase (FAAH). The cellular uptake of AEA has been characterized in detail, whereas less is known about the properties of the PEA uptake, in particular in neuronal cells. In the present study, the pharmacological and functional properties of PEA and AEA uptake have been investigated in mouse Neuro‐2a neuroblastoma and, for comparison, in rat RBL‐2H3 basophilic leukaemia cells. Saturable uptake of PEA and AEA into both cell lines were demonstrated with apparent KM values of 28 μM (PEA) and 10 μM (AEA) in Neuro‐2a cells, and 30 μM (PEA) and 9.3 μM (AEA) in RBL‐2H3 cells. Both PEA and AEA uptake showed temperature‐dependence but only the AEA uptake was sensitive to treatment with Pronase and phenylmethylsulfonyl fluoride. The AEA uptake was inhibited by AM404, 2‐arachidonoylglycerol (2‐AG), R1‐ and S1‐methanandamide, arachidonic acid and olvanil with similar potencies for the two cell types. PEA, up to a concentration of 100 μM, did not affect AEA uptake in either cell line. AEA, 2‐AG, arachidonic acid, R1‐methanandamide, Δ9‐THC, and cannabidiol inhibited PEA transport in both cell lines. The non‐steroidal anti‐inflammatory drug indomethacin inhibited the AEA uptake but had very weak effects on the uptake of PEA. From these data, it can be concluded that PEA is transported in to cells both by passive diffusion and by a facilitated transport that is pharmacologically distinguishable from AEA uptake. British Journal of Pharmacology (2001) 132, 1743–1754; doi:10.1038/sj.bjp.0704029